Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 6/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 3/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5227859 | 0.82 | IDO1 (0.60) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL27903748 | 0.81 | IDO1 (0.58) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL27543274 | 0.78 | CYP3A4 (0.60) | IDO1MAOBTAAR1MAOA | |
| SCHEMBL2755831 | 0.78 | IDO1 (0.55) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL17986258 | 0.78 | IDO1 (0.55) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL17986257 | 0.78 | IDO1 (0.55) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL1145657 | 0.78 | IDO1 (0.64) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL6667381 | 0.77 | IDO1 (0.69) | IDO1MAOBTAAR1MAOAACHE | |
| SCHEMBL27532051 | 0.77 | IDO1 (0.58) | IDO1MAOBTAAR1MAOA | |
| SCHEMBL27532081 | 0.77 | MAOB (0.47) | IDO1MAOBMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11028095-B2 | Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof | APTINYX INC. (US) | 2021-06-08 | — | — | US | disclosed |
| EP-1407667-B1 | HERBICIDE CONTAINING SUBSTITUTED PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT | SDS BIOTECH CORP (JP) | 2007-09-26 | — | — | EP | disclosed |
| EP-1464642-B1 | NOVEL SUBSTITUTED PYRAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND HERBICIDAL COMPOSITION CONTAINING THE SAME | SDS BIOTECH CORP (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7192906-B2 | Substituted pyrazole derivatives, production process thereof, and herbicide compositions containing the derivatives | SDS BIOTECH K.K. (JP) | 2007-03-20 | — | — | US | disclosed |
| EP-0945437-B1 | Pyrazolyl acrylic acid- and pyrazolyl oximino-acetic acid derivatives, their preparation and their use as fungicides | SDS BIOTECH CORP (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-20050014649-A1 | Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same | SDS BIOTECH K.K. (JP) | 2005-01-20 | — | — | US | disclosed |
| US-6809065-B2 | ON ALGAE OR WEEDS; CROP SELECTIVITY | SDS BIOTECH K.K. (JP) | 2004-10-26 | — | — | US | disclosed |
| EP-1464642-A1 | NOVEL SUBSTITUTED PYRAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND HERBICIDAL COMPOSITION CONTAINING THE SAME | SDS Biotech K.K. (JP) | 2004-10-06 | — | — | EP | disclosed |
| EP-1407667-A1 | HERBICIDE CONTAINING SUBSTITUTED PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT | SDS Biotech K.K. (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-20040033898-A1 | Herbicide containing substituted pyrazole derivative as active ingredient | SDS BIOTECH K.K. (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-0945437-A1 | Pyrazolyl acrylic acid- and pyrazolyl oximino-acetic acid derivatives, their preparation and their use as fungicides | SDS Biotech K.K. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014649-A1 | Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same | HPD, HDHD5, CYP2E1 | IDO1 2228/4885MAOB 2752/4885TAAR1 4320/4885 |
| US-11028095-B2 | Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof | GRIN1, GRIN2A, GRIN2C | IDO1 3301/4885MAOB 1806/4885TAAR1 371/4885 |
| US-20040033898-A1 | Herbicide containing substituted pyrazole derivative as active ingredient | DDT, SULT2A1, CYP2E1 | IDO1 41/4885MAOB 2829/4885TAAR1 3345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.